Pharmaceutical company Pernix Therapeutics Holdings According to Pernix Therapeutics, Zohydro ER with BeadTek is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which ... Bloomberg, 2 weeks ago
Pernix releases Zohydro ER hydrocodone capsules with BeadTek - Chain Drug Review, 2 weeks ago
1 images for "Zohydro"
Pernix Therapeutics Holdings, a specialty pharmaceutical company, reported that the new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek is now available in U.S. pharmacies. According to a release, on ...Individual.com, 2 weeks ago New Zohydro ER Formulation with Abuse-Deterrent Technology Launched Monthly Prescribing Reference, 2 weeks ago Pernix Launches Zohydro® ER with BeadTek World Energy Source, 2 weeks ago PERNIX THERAPEUTICS : Releases Pharmacokinetic Data for ZX007 Third Generation Zohydro ER on Track 4 Traders, 2 weeks ago
Pernix Therapeutics Holdings reported that it has closed its acquisition of the Zohydro ER (hydrocodone bitartrate) franchise, comprising three extended release hydrocodone products, including an abuse-deterrent pipeline and all related intellectual ...Individual.com, 3 weeks ago
(GLOBE NEWSWIRE) -- Zogenix, Inc. ( Nasdaq:ZGNX ), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, announced today that it has closed the sale of its Zohydro ® ER ...Wall Street Business Network, 4 weeks ago Zogenix divests Zohydro ER business to Pernix Bloomberg, 3 weeks ago Zogenix, Inc Closes Sale of Zohydro ER Business to Pernix Reuters UK, 3 weeks ago Zogenix Closes Sale Of Zohydro ER Business To Pernix BioSpace, 4 weeks ago
Why buy a controversial pain drug franchise that's up against some hefty competition? Pernix Therapeutics ($PTX) has one word for you: synergies. With about two-thirds of chronic pain patients also reporting poor or unrefreshing sleep, the New ...FiercePharmaMarketing, 2 months ago Pernix figures 1 + 1 + 1 equals more than three with new Zohydro salesforce FiercePharma, 2 months ago
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, has announced encouraging results from a human pharmacokinetic equivalence study with ZX007, an abuse deterrent tablet formulation of hydrocodone bitartrate in patients with ...Individual.com, 2 days ago
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, has announced the availability of the new formulation of Zohydro extended-release, or ER, capsules, CII, with BeadTek, indicated for management of chronic pain, in the US. On ...Individual.com, 3 days ago
Zogenix (NASDAQ:ZGNX) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 25,353,712 shares, a decline of 5.1% from the April 15th total of 26,730,165 shares, AnalystRatings.Net ...American Banking News, 4 days ago Zogenix Sees Significant Decrease in Short Interest (ZGNX) SleekMoney, 1 month ago
The FDA approved its first combination therapy to treat migraines in pediatric patients, giving its blessing to Pernix Therapeutics' ($PTX) Treximet for use in patients ages 12 to 17. Treximet was approved for adults in 2008, and the expanded ...Fierce Drug Delivery, 4 days ago
Zogenix (NASDAQ:ZGNX) s stock had its buy rating reaffirmed by equities research analysts at Brean Capital in a research note issued to investors on Saturday. They currently have a $12.00 target price on the stock, up from their previous target ...SleekMoney, 5 days ago Zogenix Stock Rating Reaffirmed by Oppenheimer (ZGNX) SleekMoney, 1 week ago Research Analysts Ratings Reiterations for May, 12th (ACT, NMRX, QNST, RAX, YY, ZGNX, ZSPH) American Banking News - Forex, 1 week ago Zogenix Rating Reiterated by Oppenheimer (ZGNX) American Banking News - Forex, 1 week ago
More from: , WKRB News...and 1 other sources
on your WebpageAdd Widget >Get your members hooked!